ABEOME CORPORATION

Company Information
Address GEORGIA BIOBUSINESS CTR
ATHENS, GA, 30602-1514

http://abeomecorp.com

Information

DUNS: 095542358

# of Employees: 2


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Novel Therapeutic Approach to Hypercholesterolemia Using Anti-PCSK9 Selected Immune Repertoires

    Amount: $1,482,472.00

    DESCRIPTION provided by applicant We have developed and completed a proof of principle on a new transgenic mouse model for comprehensive characterization of the antibody repertoire made in response ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  2. Novel Therapeutic Approach to Hypercholesterolemia Using Next-Generation DNA Sequ

    Amount: $242,066.00

    DESCRIPTION (provided by applicant): We have developed and completed a proof-of-principle on a new transgenic mouse model for comprehensive characterization of the antibody repertoire made in response ...

    SBIRPhase I2014Department of Health and Human Services
  3. Development of a TAVI Device with a Reduced Crossing Profile

    Amount: $275,916.00

    DESCRIPTION (provided by applicant): Obesity is considered the number one health problem in the US and Europe, affecting 10% to 30% of adult populations. Obese individuals are more likely to acquire a ...

    SBIRPhase I2013Department of Health and Human Services
  4. Development of a transgenic mouse line engineered to permit selection and cloning

    Amount: $133,995.00

    DESCRIPTION (provided by applicant): The Applicant proposes an improvement to monoclonal antibody technology through the generation of transgenic mice engineered to facilitate flow cytometric isolatio ...

    SBIRPhase I2010Department of Health and Human Services
  5. Novel Caenorhabditis Elegans Reagents

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): C. elegans is well established as a highly useful model organism. The 14th annual Biennial International C. elegans Conference held June 29th-July 3, 2003 elicited ...

    SBIRPhase I2004Department of Health and Human Services
  6. Novel Markers on Human Embryonic Stem Cells

    Amount: $100,000.00

    DESCRIPTION(provided by applicant): Embryonic stem cells (ES) are a major focus of research, because of their experimental utility and great promise as therapeutic tissue regeneration and gene replac ...

    SBIRPhase I2004Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government